株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

トランスレーショナル再生医療 - 世界市場の見通し(2017-2026)

Translational Regenerative Medicines - Global Market Outlook (2017-2026)

発行 Stratistics Market Research Consulting 商品コード 860177
出版日 ページ情報 英文 158 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.60円で換算しております。
Back to Top
トランスレーショナル再生医療 - 世界市場の見通し(2017-2026) Translational Regenerative Medicines - Global Market Outlook (2017-2026)
出版日: 2019年05月01日 ページ情報: 英文 158 Pages
概要

Stratistics MRCによると、世界のトランスレーショナル再生医療市場は2017年から2026年の間に13.9%のCAGRで成長する見通しです。退行性疾患 (変性疾患) の罹患率の増加、高齢人口の増加、先進国での成長の進展などの要因が主な要因です。

当レポートでは、世界のトランスレーショナル再生医療市場の市場トレンド、競合情勢を分析し、製品タイプ・療法・用途および地域別の市場動向、主要企業について調査しまとめています。

目次

第1章 エグゼクティブサマリー

第2章 イントロダクション

第3章 市場トレンド分析

  • イントロダクション
  • 成長要因
  • 阻害要因
  • 市場機会
  • 脅威
  • 製品分析
  • 用途分析
  • 新興市場
  • 今後の市場のシナリオ

第4章 ポーターのファイブフォース分析

  • サプライヤーの交渉力
  • バイヤーの交渉力
  • 代替品の脅威
  • 新規参入の脅威
  • 競争上の競争

第5章 世界のトランスレーショナル再生医療市場:製品タイプ別

  • イントロダクション
  • 携帯電話
  • 無細胞

第6章 世界的のトランスレーショナル再生医療市場:療法別

  • イントロダクション
  • 遺伝子治療
  • 細胞療法
  • 免疫療法
  • ヒト組織工学

第7章 世界のトランスレーショナル再生医療市場:用途別

  • イントロダクション
  • 皮膚科
  • 心血管
  • 腫瘍学
  • 糖尿病
  • 整形外科
  • 神経学
  • その他の用途

第8章 世界のトランスレーショナル再生医療市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他
  • 中東&アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他

第9章 市場の主な動向

  • 契約、提携、協業および合弁事業
  • 買収と合併
  • 新製品の発売
  • 拡張
  • その他の主な戦略

第10章 企業プロファイル

  • Vericel Corporation
  • Gamida Cell Ltd.
  • Athersys, Inc.
  • Orthofix International N.V
  • Anika Therapeutics
  • Novartis
  • Celgene Corporation
  • Brainstorm Cell Therapeutics Inc.
  • Nuvasive, Inc.
  • Medipost
図表

List of Tables

  • Table 1 Global Translational Regenerative Medicines Market Outlook, By Region (2016-2026) (US $MN)
  • Table 2 Global Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN)
  • Table 3 Global Translational Regenerative Medicines Market Outlook, By Cellular (2016-2026) (US $MN)
  • Table 4 Global Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN)
  • Table 5 Global Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN)
  • Table 6 Global Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN)
  • Table 7 Global Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN)
  • Table 8 Global Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN)
  • Table 9 Global Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN)
  • Table 10 Global Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN)
  • Table 11 Global Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN)
  • Table 12 Global Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
  • Table 13 Global Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 14 Global Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN)
  • Table 15 Global Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN)
  • Table 16 Global Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN)
  • Table 17 Global Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN)
  • Table 18 North America Translational Regenerative Medicines Market Outlook, By Country (2016-2026) (US $MN)
  • Table 19 North America Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN)
  • Table 20 North America Translational Regenerative Medicines Market Outlook, By Cellular (2016-2026) (US $MN)
  • Table 21 North America Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN)
  • Table 22 North America Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN)
  • Table 23 North America Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN)
  • Table 24 North America Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN)
  • Table 25 North America Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN)
  • Table 26 North America Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN)
  • Table 27 North America Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN)
  • Table 28 North America Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN)
  • Table 29 North America Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
  • Table 30 North America Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 31 North America Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN)
  • Table 32 North America Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN)
  • Table 33 North America Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN)
  • Table 34 North America Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN)
  • Table 35 Europe Translational Regenerative Medicines Market Outlook, By Country (2016-2026) (US $MN)
  • Table 36 Europe Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN)
  • Table 37 Europe Translational Regenerative Medicines Market Outlook, By Cellular (2016-2026) (US $MN)
  • Table 38 Europe Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN)
  • Table 39 Europe Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN)
  • Table 40 Europe Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN)
  • Table 41 Europe Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN)
  • Table 42 Europe Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN)
  • Table 43 Europe Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN)
  • Table 44 Europe Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN)
  • Table 45 Europe Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN)
  • Table 46 Europe Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
  • Table 47 Europe Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 48 Europe Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN)
  • Table 49 Europe Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN)
  • Table 50 Europe Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN)
  • Table 51 Europe Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN)
  • Table 52 Asia Pacific Translational Regenerative Medicines Market Outlook, By Country (2016-2026) (US $MN)
  • Table 53 Asia Pacific Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN)
  • Table 54 Asia Pacific Translational Regenerative Medicines Market Outlook, By Cellular (2016-2026) (US $MN)
  • Table 55 Asia Pacific Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN)
  • Table 56 Asia Pacific Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN)
  • Table 57 Asia Pacific Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN)
  • Table 58 Asia Pacific Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN)
  • Table 59 Asia Pacific Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN)
  • Table 60 Asia Pacific Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN)
  • Table 61 Asia Pacific Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN)
  • Table 62 Asia Pacific Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN)
  • Table 63 Asia Pacific Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
  • Table 64 Asia Pacific Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 65 Asia Pacific Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN)
  • Table 66 Asia Pacific Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN)
  • Table 67 Asia Pacific Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN)
  • Table 68 Asia Pacific Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN)
  • Table 69 South America Translational Regenerative Medicines Market Outlook, By Country (2016-2026) (US $MN)
  • Table 70 South America Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN)
  • Table 71 South America Translational Regenerative Medicines Market Outlook, By Cellular (2016-2026) (US $MN)
  • Table 72 South America Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN)
  • Table 73 South America Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN)
  • Table 74 South America Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN)
  • Table 75 South America Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN)
  • Table 76 South America Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN)
  • Table 77 South America Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN)
  • Table 78 South America Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN)
  • Table 79 South America Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN)
  • Table 80 South America Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
  • Table 81 South America Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 82 South America Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN)
  • Table 83 South America Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN)
  • Table 84 South America Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN)
  • Table 85 South America Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN)
  • Table 86 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Country (2016-2026) (US $MN)
  • Table 87 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN)
  • Table 88 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Cellular (2016-2026) (US $MN)
  • Table 89 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN)
  • Table 90 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN)
  • Table 91 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN)
  • Table 92 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN)
  • Table 93 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN)
  • Table 94 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN)
  • Table 95 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN)
  • Table 96 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN)
  • Table 97 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
  • Table 98 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 99 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN)
  • Table 100 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN)
  • Table 101 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN)
  • Table 102 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN)
目次

According to Stratistics MRC, the Global Translational Regenerative Medicines Market is growing at a CAGR of 13.9% from 2017 to 2026. Factors such as the increasing prevalence of degenerative diseases, rise in aging population and growing advancements in developed countries are the major driving factors. However, ethical concerns related to the use of embryonic stem cells in research & development hinders market growth.

Regenerative medicine is a segment of translational research in molecular biology and tissue engineering. It involves the process of regeneration of human cells, tissues, or organs to re-establish their normal functions through stimulation of the body's repair system. They are widely used in the treatment of many degenerative disorders occurring in the areas of dermatology, orthopedic, cardiovascular and neurodegenerative diseases.

By Product Type, the Gene therapy segment is expected to have significant growth during the forecast period. Gene therapy assists the foundation for innovative treatments of innumerable musculoskeletal disorders. By geography, North America dominated the global regenerative medicine market owing to an increased number of leading companies and growth in the expansion of research and development activities in the U.S.

Some of the key players profiled in the Translational Regenerative Medicines Market include Vericel Corporation, Gamida Cell Ltd., Athersys, Inc., Orthofix International N.V, Anika Therapeutics, Novartis, Celgene Corporation, Brainstorm Cell Therapeutics Inc., Nuvasive, Inc., and Medipost.

Product Types Covered:

  • Cell-Based Products
  • Tissue Engineered Products
  • Gene Therapy Products

Applications Covered:

  • Dermatology
  • Cardiovascular
  • Oncology
  • Diabetes
  • Orthopedic
  • Neurology
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 9 years of all the mentioned segments, , and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Futuristic Market Scenario

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Translational Regenerative Medicines Market, By Product Type

  • 5.1 Introduction
  • 5.2 Cellular
  • 5.3 Acellular

6 Global Translational Regenerative Medicines Market, By Therapy

  • 6.1 Introduction
  • 6.2 Gene Therapy
  • 6.3 Cell Therapy
  • 6.4 Immunotherapy
  • 6.5 Tissue Engineering

7 Global Translational Regenerative Medicines Market, By Application

  • 7.1 Introduction
  • 7.2 Dermatology
  • 7.3 Cardiovascular
  • 7.4 Oncology
  • 7.5 Diabetes
  • 7.6 Orthopedic
  • 7.7 Neurology
  • 7.8 Other Applications

8 Global Translational Regenerative Medicines Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Vericel Corporation
  • 10.2 Gamida Cell Ltd.
  • 10.3 Athersys, Inc.
  • 10.4 Orthofix International N.V
  • 10.5 Anika Therapeutics
  • 10.6 Novartis
  • 10.7 Celgene Corporation
  • 10.8 Brainstorm Cell Therapeutics Inc.
  • 10.9 Nuvasive, Inc.
  • 10.10 Medipost
Back to Top